Logos Global Management LP

Position in TYRA — Tyra Biosciences, Inc.

CIK 1792126 San Francisco, CA

Position in TYRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$32,555,000

+$27,034,100 QoQ

Shares Held

850,000

+304.8% QoQ

Ownership

1.42%

of shares outstanding

% of Portfolio

1.84%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Logos Global Management LP holds $2,281,179,823 across 63 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	ERAS	Erasca, Inc.	12,150,000	$222,588,000
2	ABVX	Abivax S.A.	1,024,000	$136,458,240
3	RVMD	Revolution Medicines, Inc.	700,000	$131,096,000
4	IDYA	IDEAYA Biosciences, Inc.	3,000,000	$111,810,000
5	BNTX	BioNTech SE	1,015,000	$94,445,750
6	VERA	Vera Therapeutics, Inc.	2,200,000	$94,402,000
7	TNGX	Tango Therapeutics, Inc.	2,850,000	$89,091,000
8	PRAX	Praxis Precision Medicines, Inc.	260,000	$87,045,400

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$32,555,000	850,000	+304.8%	Shares	Sole	2026-05-15
2025-12-31	$5,520,900	210,000	+558.9%	Shares	Sole	2026-02-17
2023-09-30	$438,877	31,872	0.0%	Shares	Sole	2023-11-14
2023-06-30	$542,780	31,872	-63.6%	Shares	Sole	2023-08-14
2023-03-31	$1,408,905	87,673	-20.9%	Shares	Sole	2023-05-15
2022-12-31	$842,505	110,856	-12.9%	Shares	Sole	2023-02-14
2022-09-30	$1,119,107	127,316	-23.5%	Shares	Sole	2022-11-14
2022-06-30	$1,190,660	166,526	-34.1%	Shares	Sole	2022-08-15
2022-03-31	$2,704,168	252,726	-46.6%	Shares	Sole	2022-05-16
2021-12-31	$6,660,653	473,394	-52.8%	Shares	Sole	2022-02-14
2021-09-30	$17,649,700	1,003,394	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.